Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Ad Verheul

Ad Verheul

Centre De Hartenberg Netherlands Netherlands

Ahmed M lutfi Al

Ahmed M lutfi Al

Iman university of Baghdad Iraq Iraq

Ahmet Turan ISIK

Ahmet Turan ISIK

Dokuz Eylul University Turkey Turkey

Alan M. Palmer

Alan M. Palmer

Cerebro science Ltd UK UK

Ali H Alwadei

Ali H Alwadei

National Neuroscience institue saudi arabia Saudi Arabia

Amos Korczyn

Amos Korczyn

Tel Aviv Universtiy Israel Israel

Amri Tamiz

Amri Tamiz

Nantional Institue of Health USA USA

Ana Patricia Aguilera Hermida

Ana Patricia Aguilera Hermida

Penn State university USA USA

Parkinsons Congress 2019

About Conference


On behalf of Organizing Committee we invite all the participants from all over the world to attend the Parkinsons Congress  2019 entitled 5th World Congress on Parkinsons & Huntingtons Disease August 19-20, 2019 at Vienna, Austria.

The present Parkinsons Congress focuses on Neurological disorders occurs due to loss of communication between neurons in the brain. These disorders are noted as the greatest threat to humans in present generations around globe. More than Hundred diseases are in association with nervous system including Parkinson's disease they are Alzheimer's disease, brain tumors, Multiple Sclerosis Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, Stroke and Epilepsy.

Europeans are besieged by mental and neurological illnesses, virtually 165 million people are recorded as suffering from brain disorders annually among which only third of cases receiving the surgery or medication., it found neurological disorders involve economic status about 386 billion euros ($555 billion) per year which is difficult for growing nations to overcome. This summit provides opportunity for all the applicants, professors, research students to exchange ideas, complications and innovations with one another and can collaborate. 

At National Institute of Health funding package is of $34 billion for the economic year 2017 to improve life of patients who are suffering from Parkinson’s disease and to rise the research ideas and to reduce mental disorders around globe. PRP (Parkinson's Research Program) fund received amount of $16 million annually to research in Neuromuscular disorders such as Alzheimer’s, Parkinson’s disease, Huntington’s disease.

Omics Group Organizes many conferences around globe and gathers eminent persons with an idea of Ameliorating Human life.

Why to attend?

5th World Congress on Parkinsons & Huntington Disease Acts as a single platform to unite all Scientists, Neurosurgeons, Clinician, Industry Specialists, Neurology Experts, Scholars to discuss regarding Neurological disorders with an aim to make patients feel better with innovative research outcomes. 

Target audience:

Neurologists and Directors, Neuroscientists, Physicians, Specialists, Researchers, Professors, Industrial Experts, Neurosurgeons, Psychiatrist, Nutritional Scientists, Lecturers and Students from Academia in the study of Parkinson disease, Students from Academia in the research of Neurology and Neuroscience, Therapists

 

Market Analysis

On behalf of Parkinsons congress 2019, it is cheerful in welcoming you all attendees, speakers, and exhibitors from all over the world to recognise recent research ideas in the field of neuroscience and related disorders to Europe international conference during 19-20, August 2019.

The main goal of this conference is to bring out ideas in treating Parkinsons disease and to improve the of life through advanced treating methods.

Reasons to undertake:

Parkinsons congress 2019 is conducted exclusively in support to worldwide neuro researchers. We endeavour to make Parkinsons congress 2019 a grand success, with the support of high eminent talks from the neuro science and Parkinson’s disease communities. During the time, you spend at this congress, we promise you that we will provide you with world class facilities and hospitality.

On an average 10million individuals are found to be suffering from Parkinson’s disease, from where only four percent of people with Parkinson’s disease are diagnosed before the age of 50. An estimated of 40% to 60% of Parkinson disease patients suffering from depression. United States stands in the fourth position in considering the death of people due to Parkinson’s disease. Men are recorded as most prone to Parkinson’s disease compared to women.

Parkinson Disease is a neurological disorder and the reason for the cause is remined as a question for the scientific community and thought to be because of low levels of dopamine produced by the neurons in the brain. Several treatments were identified which includes physiotherapy, surgery and yoga to solve the neurological disorders and progression of disease condition among the patient assemblies. People experience with Slowness of voluntary Movements, Decreased Facial Expression, Monotonous Speech, and decreased Eye Blinking, A shuffling gait with poor arm swing and stooped posture, Unsteady balance; difficulty rising from a sitting position, Swallowing problems in later stages.

About Austria:

This convocation will focus on the recent advances and novel ideas in each series of Parkinson’s research, and it will offer an incomparable occasion for specialists from all over the globe to meet, collaborate, and extricate with diverse scientific relations.

Vienna is the capital city of Austria, Vienna is also described as Europe's cultural capital, a metropolis with unique charm, vibrancy and flair. Vienna is a city with a very high quality of life, a feature that is highly appreciated by the many visitors who come to the Austrian capital. The city is in eastern part of Austria near to Czech Republic, Slovakia and Hungary. The Vienna Tourist Board provides comprehensive information about sights, hotels and leisure activities in Vienna to give visitors a structured overview of the many events and attractions in the city. The influx of visitors from all over the world has made Vienna the most popular urban tourist destination in Austria. Vienna is known for its high quality of life. Vienna, a city of music, city of art, city of culture, possesses a lively and vast array of cultural attractions. The city is a dream city for anyone with a romantic streak or an interest in history. Sightseeing opportunities are to be found in abundance. Austria's climate is also moderate and mild and reliably follows the four distinct seasons. Average summer temperatures range from 20°C to 30°C; the average winter temperatures are around 0°.

Focused concepts in congress:

Parkinson’s disease

Neuroscience

Neuromuscular Disorders

Environment and genetic changes involvement in neuro transmitters

Effect of free radicles and aging in patients

Diagnosis and imaging of Parkinson’s disease

Pathophysiology and neuropsychiatry

Neurogenic Orthostatic Hypotension

Parkinson’s disease condition.

Medication and surgery for Parkinson’s disease

Major Associations around the globe:

National Parkinson Foundation

American Parkinson Disease Association (APDA)

Parkinson’s disease Foundation

Movement Disorder Society of Australia

Parkinson's Unity Walk

Movement Disorder Society of Japan

Moroccan Neurological Society Movement Disorders Group

Italian Society for the Study of Parkinson Disease, Extrapyramidal Diseases and Dementia

Ecuador Movement Disorders Group

Austrian Parkinson's Disease Society

Danish Movement Disorder Society

International Parkinson and Movement Disorder Society

Parkinson’s Disease and Movement Disorders Society of India

Top universities globally working in the field of Parkinson Disease

University of Bath

The University of Queensland

University of Bristol

University of Cambridge

The Imperial College of Science and Medicine

Duke University

University of Milan

Karolinska Institute

University of Hamburg

The University of Edinburgh

University of Munich

University of Rochester

University of Zurich

Leiden University

University of Bristol

University of Helsinki

University of Freiburg

University of Frankfurt

Top universities in Austria:

Medical University of Vienna

Medical University of Innsbruck

Medical University of Graz

University of Vienna

Paracelsus Private Medical University

 

Past Conference Report

On behalf of Organizing Committee, we take an immense pleasure in announcing the inauguration of 4th World Conference on Parkinson’s and Huntington Disease -2018 during August 29-30,2018 at Zurich, Switzerland. We have received a benevolent response around the globe for Parkinsons Congress 2018. The conference was conducted with the theme “Scientific Innovations & Research Ideologies in Parkinsons and Huntington Diseases”. This conference was noticeable with the presence of eminent researchers with their novel ideas, business delegates and talented young research communities.

This conference created a platform to meet Leading World Parkinsons doctors, Neurosurgeons, Neuro radiologists, Clinicians, Deans, Care Experts, Scholars and other professionals in which many topics were discussed in depth to provide up-to-date information to the world regarding Parkinson’s disease. While, the summit ended up in providing an occasion to share concepts and practices.

The platform was decorated with peerless speakers, who enlightened the delegates with their novel research ideas and on various scientific topics related to the field of Parkinson’s disease. The eminent personalities at the conference were Chandramohan Wakade, Augusta University, USA, R C Hider King’s College London, UK, Jae Moon Lee, Kainos Medicine Inc., South Korea, Byung-Jun Park.

We take opportunity to appreciate to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Associates and Editorial Board Members of Journal of Neurological Disorders, Journal of Alzheimer Disease & Parkinsonism, Journal of Neurology & Neurophysiology and who supported the conference in every aspect for making an enormous success.

We once again thank all the communities of research for long term support and massive positive response. This encourages us to continue organizing events and conferences for advancing the Research in helping human life. Therefore, it is glad to announce commencement of "5th World congress on Parkinsons and Huntington Disease" which will be held during August 19-20, 2019 Vienna, Austria.

About Venue

About city

Vienna is an Austrian state. It is the capital of the Republic of Austria and by a long shot the biggest city in Austria with its population of in excess of 1.7 million. As you'd expect it's Austria's social, monetary, and political focus. As the previous home of the Habsburg court and its different domains, the city still has the trappings of the magnificent capital it used to be, and the memorable downtown area is recorded on the UNESCO World Legacy Rundown.

Vienna is one of the wealthiest districts in the European Association: Its gross territorial result of EUR 47,200 for every capita established 25.7% of Austria's Gross domestic product in 2013. It adds up to 159% of the EU normal. The city enhanced its situation from 2012 on the positioning of the most financially ground-breaking urban areas achieving number nine on the posting in 2015

the development and generation of wines inside the city fringes have a high socio-social esteem. The most essential business segments are exchange (14.7% of included an incentive in Vienna), logical and mechanical administrations, land and lodging exercises and assembling of merchandise. In 2012, Vienna's commitment in Austria's active and approaching remote direct ventures was of around 60%, which shows Vienna's job as a universal center point for household and outside organizations

The city of Vienna joins significance to science and look into and centres around making a positive situation for innovative work. In 2014, Vienna has obliged 1,329 research offices; 40,400 people are utilized in the Research and development area and 35% of Austria's Research and development costs are put resources into the city.

14.99 million Voyagers visited Vienna in 2016. In 2014, 6.2 million visitors visited Vienna and amounted to 13,524,266 medium-term remains. The principle markets for travellers are Germany, the Unified States, Italy and Russia. Somewhere in the range of 2005 and 2013, Vienna was the world's main goal for worldwide congresses and traditions. In 2014, 202 global gatherings were held in Vienna, making it the second most well known congress area worldwide as indicated by the measurements of the Universal Congress and Tradition Affiliation. Its biggest meeting focus, the Austria Canter Vienna (ACV) has an aggregate limit with respect to around 20,000 individuals and is arranged alongside the Assembled Countries Central command in Vienna Different focuses are the Messe Wien Show and Congress centre (up to 3,300 individuals) and the Hofburg Royal residence (up to 4,900 individuals).

 

Sessions

Session on: Parkinson Disease

Parkinson’s disease (PD) is a chronic and progressive disease of nervous system that possess symptoms which continue and become worse over time. It is the second commonest neurodegenerative disease after Alzheimer's disease, and in the UK, has a lifetime prevalence of between 0.1 and 0.3% of the population. The basic reason behind this condition is malfunction and death of vital nerve cells in brain. In normal conditions nerve cells present in the brain produces a neuro transmitter called dopamine that is responsible for signalling movement, emotions and co-ordination but in the case of diseased individual dopamine production slows down, hence the individual become unable to control the movement normally. There is no cure but treatment involves medication and surgery. Slowness of voluntary movements, reduced facial appearance, repetitious tongue, and diminished eye flashing, A shuffling gait with deprived arm swing and curved posture, Shaky stability; difficulty rising from a sitting position, Swallowing problems in later stages.

Related Parkinsons Conference | Parkinson congress | Parkinsons Disease Conference | Parkinsonism congress | Parkinson’s disease conference

13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; World Brain Congress, December 5-7, 2018 Dubai, UAE; 13th International Conference on Neurology and Brain Disorders, November 15-16, 2018 Osaka, Japan; World Neuron Congress , November 19-21, 2018 Bucharest,Romania; 5th World Parkinson Congress, June 4-7 2019; Comprehensive Review of Movement Disorders for the Clinical PractitionerInternational Parkinson & Movement Disorder Society,  Northwest Parkinson’s FoundationAmerican Neurological AssociationWorld Parkinson CoalitionAmerican Parkinson’s Disease Association

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk,

Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on:  Epidemiology of Parkinsons

Parkinsons disease is a neurodegenerative disorder and the cause of it remained a mystery to the scientific community. Researchers says by exposing to harmful chemicals and Pesticides mutations occurs in the genes and results in neurological disorders. With age, the condition of disease increases exponentially and men are in higher proportion to prone compared to women. On an average 10million individuals are found to be suffering from Parkinson’s disease, from where only four percent of people with Parkinson’s disease are diagnosed before the age of 50. An estimated of 40% to 60% of Parkinson disease patients suffering from depression. United States stands in the fourth position in considering the death of people due to Parkinson’s disease.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

 

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary,  International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society

Session on:  Neuromuscular Disorders

Neurons are the specialized cells that are responsible for communication, when they cannot produce signals communication between nervous system breaks and results in neuromuscular disorders. Most of these disorders are thought be inheritable and treatment is given to improve the life of patient and no cure is available to completely eradicate the condition.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Huntington Disease

Huntington’s disease is inherited from Parents and often symptoms will be more like Parkinson’s disease which include problem with mood, mental abilities, Swallowing, Speaking, Sleep Disturbances followed by loss of co-ordination and unsteady gait. A gene called HTT(Huntingtin) which is responsible for coding protein Huntingtin, if any mutation to that gene it will cause disturbances in the brain and results in death of brain cell and leads to Huntington’s disease. Abnormalities with the mutant huntingtin include Cardiac Failure, Weight Loss, Osteoporosis, reduced glucose level. This condition is normally observed in the individuals under the age of fifties.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; World Brain Congress, December 5-7, 2018 Dubai, UAE; 13th International Conference on Neurology and Brain Disorders, November 15-16, 2018 Osaka, Japan; World Neuron Congress , November 19-21, 2018 Bucharest,Romania; 5th World Parkinson Congress, June 4-7 2019; Comprehensive Review of Movement Disorders for the Clinical PractitionerInternational Parkinson & Movement Disorder Society,  Northwest Parkinson’s FoundationAmerican Neurological AssociationWorld Parkinson CoalitionAmerican Parkinson’s Disease Association

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society

Session on: Risk Factors of Parkinson’s disease

Symptoms and progression of disease will not be similar among the suffering individuals but people with Parkinson’s are at higher rate of developing related risks. Developing these conditions is not a certainty, only a possibility. Knowing the conditions can help a person with Parkinson’s disease or associated symptoms and helps to take preventative measures for a better life. Parkinsons disease have a chance of creating mental ailment which can be mild or serious. It includes cognition (early stage symptoms), mood, behaviour which are considered as major impairment when compared to normal populational. The common mood alterations seen in the patients are despair, eagerness, indifference.

Related Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neuromuscular Conference

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary, International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Pathophysiology and Pharmacology

Parkinson’s disease is originated because of the gradual loss of cells in the substantia nigra of the brain. Dopamine is a neurotransmitter that transmits signals between two regions of the brain to coordinate activities like movement of limbs. If there is deficiency in dopamine production results in loss of co-ordination and end up with symptoms of Parkinson’s Disease. As the disease progresses, nervous system and brain degenerates causing a higher movement disorder.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society

Session on: Diagnosis for Parkinson’s disease

Early stage identification of Parkinson’s disease is difficult but includes some imaging studies. MRI (magnetic resonance imaging) and CT (computer tomogram) are used by many physicians to find out other relating Parkinson’s diseases such as encephalitis, Tumours, Hydrocephalus. Level of dopamine release and activity of brain can easily detect using PET and SPECT examining.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; World Brain Congress, December 5-7, 2018 Dubai, UAE; 13th International Conference on Neurology and Brain Disorders, November 15-16, 2018 Osaka, Japan; World Neuron Congress , November 19-21, 2018 Bucharest,Romania; 5th World Parkinson Congress, June 4-7 2019; Comprehensive Review of Movement Disorders for the Clinical PractitionerInternational Parkinson & Movement Disorder Society,  Northwest Parkinson’s FoundationAmerican Neurological AssociationWorld Parkinson CoalitionAmerican Parkinson’s Disease Association

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Parkinson’s disease: Complications

Parkinson's disease is usually accompanied by additional problems, which may be cured and they       are thinking difficulties, swallowing problems, depression and emotional changes, sleep difficulties, constipation, blood pressure changes, fatigue, pain.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary, International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Mitochondrial Dysfunction

The known cause of Parkinson’s disease is reduced level of dopamine production by neurons in the brain but surprisingly the main cause was malfunctioning of cell organelles like mitochondria leads to increased oxidative stress which in turn results in cell death and finally ends with Parkinsons disease with motor and non-motor symptoms. The reason may be both genetic and environment factors.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Insights and therapeutics: Parkinson’s disease

No cure has been identified to Parkinson’s disease, but use of drugs can slow down the progression. Normally prescribed by physicians include change of life style, regular aerobic exercise and prescribed therapeutic supplement. It is noted that people will have beneficial effect who are taking co-enzyme Q10 during their initial stage of disease. It is unclear how genetical changes cause Parkinson disease or influence the risk of developing the disorder. Some gene mutations(alterations) such as LRRK 2, PARK 7, PINK 1, PRKN disturb the cell mechanism that breaks down undesired proteins in neurons which are responsible for dopamine production. Hence, undegraded proteins accumulate, resulting in death of vital nerve cells and subsequently lowers the level of dopamine production. In most cases of Parkinson disease, protein deposits called Lewy bodies. It is unclear whether Lewy bodies play a key role in killing nerve cells or just part of the cells which are responsible to the disease. Yoga, massage, acupuncture, meditation, music or art therapy, alexander technique is also regarding as best methods to control neurological disorders particularly Parkinson’s disease, Alzheimer’s and neuropsychiatric. Tetrabenazine, neuroleptics, mirtazapine can be taken to for treating chorea.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary,  International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

.Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Managing life with Parkinson’s disease

Since the symptoms and progression of disease are not similar among individuals early stage detection can help to reduce the worseness. Treatment and complete abolition is not known to research groups but maintaining the instructions and following the medication prescribed by physician can better the life. Individual should get practised to maintain the stress levels and depression by daily communicating with close relatives, friends. Patients can improve the life by following guidelines given by counsellor.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; World Brain Congress, December 5-7, 2018 Dubai, UAE; 13th International Conference on Neurology and Brain Disorders, November 15-16, 2018 Osaka, Japan; World Neuron Congress , November 19-21, 2018 Bucharest,Romania; 5th World Parkinson Congress, June 4-7 2019; Comprehensive Review of Movement Disorders for the Clinical PractitionerInternational Parkinson & Movement Disorder Society,  Northwest Parkinson’s FoundationAmerican Neurological AssociationWorld Parkinson CoalitionAmerican Parkinson’s Disease Association.  

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Neurosurgery

Presently Deep brain stimulation is widely recommended for improving people suffering with Parkinson’s disease one is deep brain stimulation (DBS) and is performed by inserting a tube in the small intestine and is used to treat a variety of deactivating neurological symptoms most commonly the draining symptoms of Parkinson’s disease (PD), such as tremor, rigidity, stiffness, slowed movement, and walking problems. There will be no effect with using DBS to healthy brain tissue by terminating nerve cells. Instead the procedure blocks electrical signals from targeted areas in the brain.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Free Radicles and Aging in Parkinsons

Free radicles have both beneficial and baleful effect to human body. These are produced with in the body by metabolism and enters body through external sources such as pollution, radiation, therapeutics etc; Oxidative stress is known to cause many neurological diseases such as Alzheimer’s, Parkinson’s disease, Amyotrophic lateral sclerosis(ALS). With oldness, there is a typical failure of the dopamine producing neurons. Out of surprise 2% of the 1 million people with the disease are thought to be below the age of fifty. In some of the rare situations symptoms are seen in children and teens and it is known as juvenile parkinsonism.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Novel Therapeutics

The commonly used drug to treat Parkinson’s disease is Levodopa which has higher frequency to develop motor Fluctuations and results in L-dopa-induced dyskinesia (LID). Since the Characteristic key cause of Parkinson’s disease is reduced production level dopamine by neurons, research studies developed a molecule called LXR (Liver X Receptor) where it has got potential to reduce the loss of dopaminergic neurons. Researchers propose novel ideas to treat Parkinson’s disease to reduce the risk of causing side effects, frequency of dyskinesia, to treat cognitive disorders such as anxiety and depression.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary, International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

Session on: Clinical Trials in Parkinsonism

To develop a promising drug or treatment for Parkinson’s disease observational study is being conducted by scientist in laboratory to provide patients with better life. Clinical trials are performed to slowdown the progression and reduce the symptoms.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

11th International Conference on Vascular dementia Feb 15-16, 2019 at Amsterdam, Netherlands,  28th World Conference on Neurology and Therapeutics February 28 - March 02, 2019 in Berlin, Germany,  Annual Congress on Neurology and Neuroscience March 14-15, 2019 at Paris, France, 8th International Conference on Brain Injury and Neurological Disorders March 14-15, 2019 in Paris, France, 24th International Conference on Neurosurgery and Neuroscience, March 18-20, 2019 Edinburgh, Scotland, 23rd International Conference on Neurology and Neurophysiology, March 18-19, 2019 in Edinburgh, Scotland,  World Depression Congress, March 18-20, 2019 at Dubai, UAE, 11th World Congress on Alzheimer's Disease and Dementia,  March 20-21, 2019 at Sydney, Australia, 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 at Osaka, Japan, 31st World Neuroscience Congress Osaka, Japan during March 25-26, 2019, International Conference & Exhibition on Addictive Disorders & Addiction Therapy, March 25-26, 2019 in Yokohama, Japan, 26th World Congress on Neurology and Neurodisorders April 22-23, 2019 at Tokyo, Japan, 5th International Conference on Spine and Spinal Disorders, April 25th & 26th, 2019 at Rome, Italy, 5th Global Experts Meeting on Parkinsons, Huntingtons Movement Disorders, May 08 – 09,2019 Tokyo, Japan, 5th International Conference on Neurological Disorders and Stroke may 20-21,2019 at Osaka, Japan,  28th World Congress on Neurology & Neuroscience, Zurich, Switzerland, May 23-24, 2019, 5th International Conference on Epilepsy & Treatment  on August 19-20, 2019 at Vienna, Austria, 3rd International Congress on Addictive Behavior & Dual Diagnosis on September 05-06, 2019 at Budapest, Hungary, 30th International Conference on Public Mental Health and Neuroscience held amid September 23-24, 2019 in Abu Dhabi, UAE, 32nd Clinical Neuroscience and Neurogenetics Conference, November 19-20, 2019 in Istanbul, Turkey

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society

To Collaborate Scientific Professionals around the World

Conference Date August 19-20, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by